In conclusion, the evidence of the results from the present meta-analysis support an association between the PAI-1 4G/5G polymorphism and increasing cancer risk, especially among Caucasians, and those with colorectal cancer and endometrial cancer or cancers identified in the other cancers group, though significant heterogeneity from included studies existed. The gene discussed is SERPINE1; the disease is colorectal cancer.